A Cohort Establishment Study of Total Management of Ovarian Cancer

Launched by SICHUAN CANCER HOSPITAL AND RESEARCH INSTITUTE · Aug 30, 2023

Keywords

ClinConnect Summary

This clinical trial is focused on improving the management of ovarian cancer, which includes cancers of the ovaries, fallopian tubes, and the lining of the abdomen. Researchers are looking to gather information about how best to treat and support women with these conditions. The study is currently recruiting female patients who have been diagnosed with ovarian cancer and plan to receive treatment at the participating hospital. To be eligible, patients must be able to participate in follow-up visits, but those with other types of cancer or cognitive impairments cannot join the trial.

Participants in this study can expect to receive comprehensive care and support tailored to their specific needs. By joining, they will help researchers gather valuable information that could improve the treatment and management of ovarian cancer for future patients. This trial is an important step towards enhancing our understanding and approach to treating this disease.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients diagnosed with ovarian cancer (including fallopian tube cancer, primary peritoneal cancer) and intended to be treated in our hospital;
• • 2. Can cooperate with later follow-up.
• Exclusion Criteria:
• • 1. Patients with other malignant tumors or previous history of other malignant tumors;
• • 2. Have cognitive impairment.